Here are 4 ASX biotechs with major milestones coming right up!

February 24, 2026

Investing in ASX biotechs is a risky business, even more than most other companies on the market. Unless you own…

An Australian Investor’s Guide to Cryptocurrency in 2026!

February 24, 2026

At Stocks Down Under, we’ve written a lot about crypto, but we have never written a broad Guide to Cryptocurrency…

If you decide to start investing in 2026, here’s how you should approach it

February 24, 2026

If you want to start investing in 2026 to say it is a turbulent environment is an understatement. An undercurrent…

Woolworths vs Coles: Which Supermarket Stock Wins This Reporting Season?

February 24, 2026

Woolworths vs Coles: Margin pressure meets reporting season Woolworths Group (ASX: WOW) and Coles Group (ASX: COL) are both reporting…

Is Fisher & Paykel Healthcare (ASX:FPH) a Buy After Upgrading Guidance? The Tariff Risk Investors Are Ignoring

February 24, 2026

Fisher & Paykel Healthcare (ASX: FPH) lifted its FY26 guidance on Monday, now expecting around NZ$2.30 billion in revenue and…

Electro Optic Systems (ASX:EOS) A 20% Re Rate on Confidence, Not Clean Earnings

February 23, 2026

Contracted Revenue Up 238%, Market Looks Through the Noise Electro Optic Systems had a pretty substantial re rate, up 20%.…

Trump’s 15% Global Tariff, Why Markets Barely Blinked

February 23, 2026

Trump’s New 15% Import Tariff On Saturday, Donald Trump announced a new 15% global tariff on virtually all imports entering…

Nuix (ASX:NXL) Looks Cheap on 6x EBITDA, Is the Turnaround Real?

February 23, 2026

The Nuix Flywheel Is Turning, Bigger Deals, Better Margins Nuix is one to keep on the watchlist. At first glance,…

Anthropic: This 5-year old US$380bn company is behind ChatGPT’s rival Claude and could IPO later this year!

February 23, 2026

Anthropic did not even exist 5 years ago, but its most recent funding round valued it at US$380bn. The company…

Here are 6 of the best results this ASX reporting season (so far), and 6 of the worst!

February 23, 2026

This article recaps some of the best results this ASX reporting season so far, as well as some of the…

Austal (ASX:ASB) Wins A$4bn Navy Deal: Is It Time to Buy the Dip?

February 21, 2026

Austal’s Defence Surge: What Investors Should Watch Austal (ASX: ASB) closed at A$6.30 on Friday, up 5.53% on the day,…

Oil Surges on Iran Crisis: Best ASX Energy Stocks to Buy Now

February 21, 2026

ASX Energy Stocks: What the Oil Spike Means Now Oil prices surged more than 5% in just two trading sessions…

ASX Reporting Season Halftime Report: 4 Stocks to Buy, Hold, or Avoid After This Week’s Results

February 21, 2026

ASX Reporting Season: What This Week’s Results Mean for Investors We are halfway through the ASX reporting season, and the…

Rio Tinto (ASX:RIO) Drops 3% Despite Record Copper Output: Is This a Buying Opportunity for Income Investors?

February 21, 2026

Rio Tinto’s FY2025 Result: What Income Investors Should Know Rio Tinto (ASX: RIO) dropped 3.1% to A$163.30 on Friday after…

Long-term vs. Day Trading: Choosing Your Winning Strategy for Your ASX Portfolio

February 20, 2026

When it comes to investing in the Australian Securities Exchange (ASX), two predominant strategies often emerge: long-term investing and day…